Oragenics, Inc. Chief Medical Officer, Dr. James P. Kelly, to Participate in the 12th Annual Brain Health Summit at the Leigh Steinberg Super Bowl Party 2025

Core Insights - Oragenics, Inc. is participating in the 12th Annual Brain Health Summit to discuss advancements in concussion treatment and brain health [1][2] - The summit aims to raise awareness and explore innovative approaches to treating traumatic brain injuries (TBI) [1][2] Company Overview - Oragenics is a biotechnology company focused on developing nasal delivery systems for neurological treatments and infectious diseases, including mild traumatic brain injury (mTBI) and Niemann Pick Disease Type C (NPC) [4] - The company is advancing its intranasal neurosteroid, ONP-002, to address unmet needs in concussion treatment [3] Event Details - The Brain Health Summit, hosted by Leigh Steinberg, will feature discussions on the long-term impacts of TBIs and strategies for prevention [2][3] - Dr. Nicole Roberts will moderate the event, emphasizing health innovation and its impact on vulnerable populations [3]